Shannon James Samuel 4
4 · Xilio Therapeutics, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Shannon James Samuel
Director
Transactions
- Purchase
Common Stock
2025-06-16$0.69/sh+45,000$30,870→ 45,000 total - Purchase
Common Stock
2025-06-17$0.69/sh+25,000$17,215→ 70,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6891 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6659 to $0.6991 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.